7-(2-BUTYN-1-YL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-8-(3-OXO-1-PIPERIDINYL)-1H-PURINE-2,6-DIONE

UNII:	OG9YP6VJP9
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₂₅N₇O₃
Preferred Substance Name:	7-(2-BUTYN-1-YL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-8-(3-OXO-1-PIPERIDINYL)-1H-PURINE-2,6-DIONE
InChIKey:	QCBMVKOKWAMHHW-UHFFFAOYSA-N
GSRS Full Record:	OG9YP6VJP9 i

1807608-27-0
1H-PURINE-2,6-DIONE, 7-(2-BUTYN-1-YL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-8-(3-OXO-1-PIPERIDINYL)-
CD10604
CD10604BS
LINAGLIPTIN METABOLITE CD10604

Common Chemistry
i
Inxight Drugs
i
PubChem
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

7-(2-BUTYN-1-YL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-8-(3-OXO-1-PIPERIDINYL)-1H-PURINE-2,6-DIONE

Synonyms and Mappings

Resources